saigonbao.com
Pharmaceutical Industry
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
Pharma digs in on changes it wants from Trump administration
Process digitization in the pharmaceutical industry: a lever for productivity and compliance
Pharma trends and predictions for 2025: An incoming CEO’s perspective
Pharma Market Forecast: Top Trends for Pharma in 2025
Ionis Pharmaceuticals EVP sells $213,889 in stock
Pharma’s Big Meeting in US Draws Protests Over Healthcare Costs
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential
Drugs Licensed
Government picks 15 more prescription drugs for Medicare price negotiation
AbbVie secures option to license Simcere's blood cancer drug candidate
China's Simcere Pharma grants AbbVie option to license its blood cancer drug candidate
Most online pharmacies are run illegally and could be selling dangerous or ineffective drugs, U.S. warns
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
Man admits selling unapproved drugs used in bodybuilding through Kalispell business
Illinois AG starts crackdown on weight-loss drug copycats
Drugs Patents
Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs
JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
Gilead, government settle HIV drug patent dispute
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
High Court Axes Edwards' Bid to Limit Drug-Patent Safe Harbor
Litigators of the (Past) Week: Defending Against a $290M Claim and Scoring a $116M Win in Drug Patent Fight
Gilead reportedly settles CDC patent dispute over HIV drugs
Federal Circuit Upholds Validity of Entresto Patent In Precedential Decision Concerning Written Description and Enablement
Drugs Generics
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
US appeals court reinstates pause on generic version of Novartis' Entresto
Novartis wins temporary pause to Entresto generic launch in US
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Biden administration picks 15 more drugs for Medicare negotiation
Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto
Regulator accuses drug middlemen of wild price hikes, possibly steering business to themselves
FDA Food and Drug Administration
FDA orders manufacturers to do a better job detecting bird flu in raw pet food
RFK Jr. petitioned FDA in 2021 to revoke authorization of all COVID vaccines
Now that the FDA has banned red dye No. 3, what about more common food dyes?
Yogurt Recall Update As FDA Sets Risk Level Over Plastic Contamination
US FDA approves AstraZeneca's drug for breast cancer
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
FDA moves to cut nicotine from cigarettes, in plan first floated under Trump
FDA ban on dye Red 3 sparks calls for more food safety reform: "It's about time"
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Pharmaceutical Companies
Ionis Pharmaceuticals EVP Brian Birchler sells $176,580 in stock
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
Pharmaceutical companies spike EpiPen prices 600% while allegedly deceiving Hoosier consumers
Pharmaceutical companies conspired to spike EpiPen prices by 600%: lawsuit from Indiana Attorney General alleges
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside Potential
Is Recursion Pharmaceuticals Stock a Buy?
‘The bar has risen’: China’s biotech gains push US companies to adapt